AI-generated summary
In this double-blind randomized trial of 96 patients with seasonal affective disorder, the authors report that both bright light therapy and fluoxetine were associated with significant, comparable improvements in quality of life over 8 weeks. The improvement in quality of life was strongly associated with reduced depression symptoms. The authors note that the study was limited to a single trial in this patient group.
- Participants
- 96
- Who or what was studied
- Patients diagnosed with seasonal affective disorder who met strict diagnostic criteria
- Limits stated in the abstract
- The abstract does not describe limitations beyond the study being a single trial, so limitations are unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cambridge.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.